Laurence Duplomb
Université de Bourgogne · 87 works · 3,790 citations · h-index 36
Top works
- PIK3R1 Mutations Cause Syndromic Insulin Resistance with Lipoatrophy
- Hyperleptinemia prevents lipotoxic cardiomyopathy in acyl CoA synthase transgenic mice
- Hepatic insig-1 or -2 overexpression reduces lipogenesis in obese Zucker diabetic fatty rats and in fasted/refed normal rats
- Interleukin‐34 is expressed by giant cell tumours of bone and plays a key role in RANKL‐induced osteoclastogenesis
- The dual role of IL-6-type cytokines on bone remodeling and bone tumors
- Interleukin-6 Inhibits Receptor Activator of Nuclear Factor κB Ligand-Induced Osteoclastogenesis by Diverting Cells into the Macrophage Lineage: Key Role of Serine727 Phosphorylation of Signal Transducer and Activator of Transcription 3
- In-Frame Mutations in Exon 1 of SKI Cause Dominant Shprintzen-Goldberg Syndrome
- RANKL, RANK, osteoprotegerin: key partners of osteoimmunology and vascular diseases
- Oncostatin M Regulates the Synthesis and Turnover of gp130, Leukemia Inhibitory Factor Receptor α, and Oncostatin M Receptor β by Distinct Mechanisms
- Concise Review: Embryonic Stem Cells: A New Tool to Study Osteoblast and Osteoclast Differentiation
- De novo truncating variants in the intronless IRF2BPL are responsible for developmental epileptic encephalopathy
- Cohen syndrome is associated with major glycosylation defects
- Lysosomal Signaling Licenses Embryonic Stem Cell Differentiation via Inactivation of Tfe3
- The DYRK1A gene is a cause of syndromic intellectual disability with severe microcephaly and epilepsy
- Osteoprotegerin: Multiple partners for multiple functions
- The Mannose 6-Phosphate/Insulin-like Growth Factor II Receptor Is a Nanomolar Affinity Receptor for Glycosylated Human Leukemia Inhibitory Factor
- Stimulation of Leukemia Inhibitory Factor Receptor Degradation by Extracellular Signal-regulated Kinase
- Autosomal-recessive SASH1 variants associated with a new genodermatosis with pigmentation defects, palmoplantar keratoderma and skin carcinoma
- Key roles of the OPG–RANK–RANKL system in bone oncology
- Changing facial phenotype in Cohen syndrome: towards clues for an earlier diagnosis